Skip to content

Evaluation of the Accuracy of SmartRobin@AI

Evaluation of the Accuracy of SmartRobin@AI, a Long-Term Electrocardiogram Analysis Software, in Real Clinical Settings

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1042230125
Enrollment
100
Registered
2024-01-09
Start date
2024-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation Atrial Fibrillation, Arrhythmia

Interventions

None listed

Sponsors

Osanai Hiroyuki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who underwent electrocardiogram examinations at our clinic from January 1, 2023, to August 31, 2023, and whose electrocardiographic waveforms were analyzed using the SmartRobin AI series.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Diagnosis rate, sensitivity, specificity of AF

Secondary

MeasureTime frame
Background Factors in SmartRobin AI Positive Cases (including False Positives): Hypertension Complications of Heart Failure Advanced Age/75 years or older Diabetes Stroke Gender Background Factors in SmartRobin AI True Positive Cases: Hypertension Complications of Heart Failure Advanced Age/75 years or older Diabetes Stroke Gender

Contacts

Public ContactMineki Takechi

Cardio Intelligence Co., Ltd.

contact-ci-info@cardio-i.com+81-3-6821-0390

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026